The disclosure of transfers of values to Healthcare Professionals (HCP) and Healthcare Organisation (HCO) is part of the transparency initiative developed by the European Federation of Pharmaceutical Industries and Associations and the Association of Pharmaceutical Manufacturers (LMI).
Servier adheres and fully supports the objectives promoted through this self-regulatory initiative.
Pharmaceutical companies have to interact with the medical community in order to advance scientific knowledge and improve patient care. These interactions regularly imply important work/time/involvement from HCP and HCO, like for example the setting and follow up of clinical trials. The outcome of this publication will contribute to provide a better insight on our interactions.
For United Kingdom, the publication of Servier’s transfers of values is available here:
This publication has been prepared in accordance with the United Kingdom methodological note and the requirements of the LMI Code. The interactions listed in this document include all transfers of values made from 1st January to 31st December by all companies of the Servier Group, locally or from foreign countries.
You can contact us for any question in the information provided in this section and also find more information on the publication made by Servier in other countries.